Nidan Labs & Healthcare logo

Nidan Labs & Healthcare

NIDAN NSE

Key Fundamentals

SMEHealthcare Service ProviderHealthcare Services
Market Cap
₹18.28 Cr
Volatility
Moderate
P/E Ratio
12.2
EBITDA
₹4.44 Cr
Return on Equity
2.9%
Debt to Equity
0.16
Book Value
₹50.14
EPS
₹1.5
52W High
₹24.9
52W Low
₹11.5

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Stock is trading at 0.27 times its book value
  • Company's working capital requirements have reduced from 87.8 days to 33.6 days

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 4.62% over past five years.
  • Company has a low return on equity of 1.81% over last 3 years.
  • Promoter holding has decreased over last 3 years: -14.2%

Growth Rate

Revenue Growth
-4.7% lower than 3Y
Net Income Growth
-18% higher than 3Y
Cash Flow Change
-58.7% higher than 3Y
ROE
-159% lower than 3Y
ROCE
—
EBITDA Margin (Avg.)
-40.68% higher than 3Y

Quarterly Results

Particulars Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
13.14
14.09
10.18
11.82
12.35
10.53
13.99
13.12
12.42
Expenses
9.52
8.93
8.54
8.48
9.24
7.93
11.53
10.58
10.12
Operating Profit
3.62
5.16
1.64
3.34
3.11
2.6
2.46
2.54
2.3
OPM %
27.55%
36.62%
16.11%
28.26%
25.18%
24.69%
17.58%
19.36%
18.52%
Other Income
0.39
0.33
3
1.52
-5.29
1.03
1.22
1.17
0.29
Interest
0.95
1.03
1.19
0.98
1.2
0.88
1.26
0.88
1.07
Depreciation
0.87
1.44
1.66
1.28
1.59
1.34
1.07
0.92
0.98
PBT
2.19
3.02
1.79
2.6
-4.97
1.41
1.35
1.91
0.54
Tax %
61.19%
23.51%
31.28%
26.15%
3.62%
21.99%
34.81%
24.61%
87.04%
Net Profit
0.86
2.32
1.22
1.92
-5.15
1.1
0.88
1.43
0.07
EPS in Rs
0.62
1.67
0.88
1.38
-3.71
0.79
0.63
1.03
0.05
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
20.07
21.41
20.38
29.66
24.27
24.18
24.53
25.54
Expenses
12.23
13.78
11.49
20.25
17.47
17.74
19.47
20.7
Operating Profit
7.84
7.63
8.89
9.41
6.8
6.44
5.06
4.84
OPM %
39.06%
35.64%
43.62%
31.73%
28.02%
26.63%
20.63%
18.95%
Other Income
0.37
0.01
1.06
0.4
3.33
-3.76
2.25
1.46
Interest
4.75
3.74
3.46
2.66
2.22
2.18
2.14
1.96
Depreciation
3.24
3.19
3.18
2.63
3.1
2.87
2.41
1.9
PBT
0.22
0.71
3.31
4.52
4.81
-2.37
2.76
2.44
Tax %
0%
0%
30.21%
41.15%
26.4%
36.29%
28.26%
38.11%
Net Profit
0.22
0.71
2.3
2.66
3.54
-3.23
1.98
1.51
EPS in Rs
0.22
0.72
2.32
1.91
2.55
-2.32
1.42
1.09
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
9.9
9.9
9.9
13.9
13.9
13.9
13.9
13.9
Reserves
0.41
1.13
3.43
52
55.54
52.31
54.28
55.79
Borrowings
32.16
34.35
38.04
19.29
10.93
12.44
11.11
11.17
Other Liabilities
0.58
-0.17
2.37
3.29
4.03
3.9
3.65
3.14
Total Liabilities
43.05
45.21
53.74
88.48
84.4
82.55
82.94
84
Fixed Assets
23.28
20.1
19.92
20.46
21.39
17.95
16.33
14.91
CWIP
0
0
0.23
3.81
0
0.04
0.15
0.15
Investments
0.53
0.53
0.27
0
0
0
20
20
Other Assets
19.24
24.58
33.32
64.21
63.01
64.56
46.46
48.94
Total Assets
43.05
45.21
53.74
88.48
84.4
82.55
82.94
84
Figures in ₹ Crores

Cash Flow

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
8.95
4.62
4.35
7.83
10.97
5.52
2.28
1.67
Investing
1
-0.01
-3.22
-35.74
-0.29
-10.6
-0.22
0.06
Financing
-5.81
-1.56
-1.22
28.72
-10.37
-0.49
-3.01
-1.63
Net Cash Flow
4.14
3.05
-0.1
0.8
0.32
-5.57
-0.95
0.1
Free Cash Flow
9.95
4.61
1.13
1.36
11.02
4.88
1.41
1.19
CFO/OP
114
61
49
96
162
129
77
55
Figures in ₹ Crores

Ratios

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
102
92.57
97.25
65.96
90.69
7.85
18.9
31.73
Inventory Days
16.98
12.88
18.17
25.99
—
—
—
—
Days Payable
117
-25.76
213
136
—
—
—
—
Cash Conversion Cycle
2.29
131
-97.64
-43.89
90.69
7.85
18.9
31.73
Working Capital Days
256
292
-189
54.52
43.46
243
-13.39
33.58
ROCE %
—
10.13%
13.99%
10.09%
8.17%
7.95%
6.17%
5.99%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Nidan Labs & Healthcare insights

54 extracted metrics + investor summaries across FY19–FY26.

Log in — free

Shareholding Pattern

Promot.57.04%Others3.02%Public39.94%As ofJun 2026

Documents

Frequently Asked Questions about Nidan Labs & Healthcare

What does Nidan Laboratories & Healthcare Ltd do?
Incorporated in 2000, Nidan Laboratories & Healthcare Ltd is in the business of providing various Healthcare and Diagnostics Services[1]
Where is Nidan Laboratories & Healthcare Ltd (NIDAN) listed?
Nidan Laboratories & Healthcare Ltd trades as NIDAN on the NSE.
Which sector does Nidan Laboratories & Healthcare Ltd belong to?
Nidan Laboratories & Healthcare Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Nidan Laboratories & Healthcare Ltd?
Nidan Laboratories & Healthcare Ltd has a market capitalisation of ₹18.28 Cr, which places it in the Small Cap band.
What is the PE ratio of Nidan Laboratories & Healthcare Ltd?
Nidan Laboratories & Healthcare Ltd trades at a PE ratio of 12.20, on earnings per share of ₹1.5, against a book value of ₹50.14 per share.
What is the 52-week high and low of Nidan Laboratories & Healthcare Ltd?
Over the last 52 weeks Nidan Laboratories & Healthcare Ltd has traded between ₹11.5 and ₹24.9.
What is the Return on Equity (ROE) of Nidan Laboratories & Healthcare Ltd?
Nidan Laboratories & Healthcare Ltd reported a return on equity of 2.90%. Its debt-to-equity ratio is 0.16.

Company Information

Incorporated in 2000, Nidan Laboratories & Healthcare Ltd is in the business of providing various Healthcare and Diagnostics Services[1]

Website nidanhealthcare.co.in
Listed 2021-11-12
Face Value ₹ 10
Issued Size 1,39,00,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NIDAN.md for Nidan Laboratories & Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List